Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats

Abstract

Abstract The author has withdrawn this article 1 from the public domain because they did not have permission to use the data that was presented within. In the light of this situation, BioMed Central regrets that this article is no longer available. The author apologises to all parties for the inconvenience.